Mortality trends of cutaneous melanoma in Colombia

Authors

  • María Alejandra García

DOI:

https://doi.org/10.29176/2590843X.317

Keywords:

Melanoma, mortality rate, Colombia, skin neoplasms

Abstract

Background: Cutaneous melanoma is a highly lethal cancer within skin tumors. The rapid increase in total cases in the last decade has turned this cancer to be a priority for public health worldwide. Even though the majority of the Colombian population has a low-risk skin prototype, Colombia is the fourth country in Background: Cutaneous melanoma is a highly lethal cancer within skin tumors. The rapid increase in total cases in the last decade has turned this cancer to be a priority for public health worldwide. Even though the majority of the Colombian population has a low-risk skin prototype, Colombia is the fourth country in America with higher incidence. Materials and methods: The numbers of fatal cases of cutaneous mela- noma that occurred in Colombia from 2000 to 2012 was obtained from the mortality records of the Departamento Administrativo Nacional de Estadística (DANE). Total mortalities were analyzed globally and according to age and according toage and gender. Mortality rates and their tendency over time were estimated at a national, departmental and regional level; moreover, the relationship between mortality rates and date of death were analyzed using the Poisson regression model. Results and conclusions: Between the years 2000 and 2012, 2,904 people died from cutaneous melanoma in Colombia. The mortality risk of cutaneous melanoma had a constant increase during this period; adjusted rate by age of 3.8 by the 2000 and 6.6 by 2012 (rate ratio=1.75; CI 95% 1.4-2.1). The mortality-year rise varied depending on age, region and gender. In Colombia, mortality by cutaneous melanoma is increasing. In order to avoid its progression, it is necessary to create educational combined strategies as a tool for primary, as well as, secondary prevention.

Author Biography

María Alejandra García

Médica y cirujana de la Pontificia Universidad Javeriana, epidemióloga de la Universidad Autónoma de Madrid; residente de Otorrinolaringología, Fundación Universitaria de Ciencias de la Salud-Hospital de San José, Bogotá, D.C., Colombia.

References

Desmond RA, Soong S. Epidemiology of malignant melanoma. Surg Clin North Am. 2003;83:1-29.

https://doi.org/10.1016/S0039-6109(02)00092-0

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34.

https://doi.org/10.1200/JCO.2001.19.16.3622

WHO. Globocan 2012, Melanoma of the skin-Estimated Incidence and Mortality. GLOBOCAN 2012: Estimate cancer Incidence, Mortality and Prevalence Worlwide in 2012. Fecha de consulta: 3 de julio de 2015. Disponible en: http://globocan.iarc.fr/Default.aspx

Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer Oxf Engl 1990. 2005;41:45-60.

https://doi.org/10.1016/j.ejca.2004.10.016

Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27:3-9.

https://doi.org/10.1016/j.clindermatol.2008.09.001

Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989;262:2097-100.

https://doi.org/10.1001/jama.1989.03430150065027

Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678-83.

https://doi.org/10.1093/jnci/93.9.678

Héry C, Tryggvadóttir L, Sigurdsson T, Olafsdóttir E, Sigurgeirsson B, Jonasson JG, et al. A melanoma epidemic in Iceland: Possible influence of sunbed use. Am J Epidemiol. 2010;172:762-7.

https://doi.org/10.1093/aje/kwq238

Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: Changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst. 2000;92:811-8.

https://doi.org/10.1093/jnci/92.10.811

Miller DR, Geller AC, Wyatt SW, Halpern A, Howell JB, Cockerell C, et al. Melanoma awareness and self-examination practices: Results of a United States survey. J Am Acad Dermatol. 1996;34:962-70.

https://doi.org/10.1016/S0190-9622(96)90273-X

Tryggvadóttir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, et al. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol Stockh Swed. 2010;49:665-72.

https://doi.org/10.3109/02841861003702528

Hollestein LM, van den Akker SA, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E. Trends of cutaneous melanoma in The Netherlands: Increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol. 2012;23:524-30.

https://doi.org/10.1093/annonc/mdr128

Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011;65:S17.e1-11.

https://doi.org/10.1016/j.jaad.2011.04.032

Hoejberg L, Gad D, Gyldenkerne N, Bastholt L; Academy of Geriatric Cancer Research (AgeCare). Trends in melanoma in the elderly in Denmark, 1980-2012. Acta Oncol. 2016;55(Suppl.1):52-8.

https://doi.org/10.3109/0284186X.2015.1114677

Giblin A-V, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthetic Surg. 2007;60:32-40.

https://doi.org/10.1016/j.bjps.2006.05.008

Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health. 2005;29:383-6.

https://doi.org/10.1111/j.1467-842X.2005.tb00211.x

Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95:91-5.

https://doi.org/10.1038/sj.bjc.6603216

Sneyd MJ, Cox B. A comparison of trends in melanoma mortality in New Zealand and Australia: The two countries with the highest melanoma incidence and mortality in the world. BMC Cancer. 2013;13:372.

https://doi.org/10.1186/1471-2407-13-372

Boniol M, Autier P, Gandini S. Melanoma mortality following skin cancer screening in Germany. BMJ Open. 2015;5:e008158.

https://doi.org/10.1136/bmjopen-2015-008158

Watson M, Geller AC, Tucker MA, Guy GP, Weinstock MA. Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States. Prev Med. 2016;91:294-8.

https://doi.org/10.1016/j.ypmed.2016.08.032

Sánchez G, Nova J. Confiabilidad y reproducibilidad de la escala de fototipos de Fitzpatrick antes y después de un ejercicio de estandarización clínica. Biomédica. 2008;28:544-50.

https://doi.org/10.7705/biomedica.v28i4.59

Universidad del Valle. Registro Poblacional de Cáncer de Cali, Colombia. Melanoma, 1962-2010. RPCC: Registro Poblacional de Cáncer de Cali. Fecha de consulta: 30 de junio de 2015. Disponible en: http://rpcc.univalle.edu.co./es/index.php

Erdmann F, Lortet-Tieulent J, Schüz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer. 2013;132:385-400.

https://doi.org/10.1002/ijc.27616

Schmerling RA, Loria D, Cinat G, Ramos WE, Cardona AF, Sánchez JL, et al. Cutaneous melanoma in Latin America: The need for more data. Rev Panam Salud Pública Pan Am J Public Health. 2011;30:431-8.

https://doi.org/10.1590/S1020-49892011001100005

Chang C, Murzaku EC, Penn L, Abbasi NR, Davis PD, Berwick M, et al. More skin, more sun, more tan, more melanoma. Am J Public Health. 2014;104:e92-9.

https://doi.org/10.2105/AJPH.2014.302185

Oliveros C, Bravo JC, Zambrano A, Cepeda M, Ramírez AF. Tendencia de la incidencia y la mortalidad en melanoma maligno en los últimos 60 años y análisis de los datos del Registro Poblacional (sic.) de Cáncer de Cali. Rev Asoc Colomb Dermatol. 2012;20:255-64.

https://doi.org/10.29176/2590843X.236

Pozzobon FC. Epidemiología del melanoma en el Instituto Nacional de Cancerología, 2006-2010. Bogotá, Colombia. Universidad Nacional de Colombia; 2012. Fecha de consulta: 5 de julio de 2015. Disponible en: http://www.bdigital.unal.edu.co/11513/1/05598712.2012.pdf

Departamento Administrativo Nacional de Estadistica (DANE). Proyeccion poblacional 1985-2020. DANE. Fecha de consulta: 3 de julio de 2015. Disponible en:http://www.dane.gov.co/index.php/poblacion-y-demografia/proyecciones-de-poblacion

Bray F. Cancer incidence in five continents. Age-standardization. Lyon: ARC Scientific Publications; 2002;8:87-9.

Hinde J. Compound poisson regression models. In: Gilchrist R, editor. GLIM 82: Proceedings of the International Conference on Generalised Linear Models.New York:Springer; 1982. p. 109-21.Fecha de consulta: 7 de julio de 2015. Disponible en:http://link.springer.com/chapter/10.1007/978-1-4612-5771-4_11

https://doi.org/10.1007/978-1-4612-5771-4_11

Nova-Villanueva J, Sánchez-Vanegas G, Porras de Quintana L. Cáncer de piel: perfi l epidemiológico de un centro de referencia en Colombia 2003-2005. Revista de Salud Pública. 2007;9:595-601.

https://doi.org/10.1590/S0124-00642007000400012

Aceituno-Madera P, Buendía-Eisman A, Olmo FJ, Jiménez-Moleón JJ, Serrano-Ortega S. Melanoma, altitud y radiación UVB. Actas Dermosifiliogr.2011;102:199-205.

https://doi.org/10.1016/j.ad.2010.08.003

Municipios de Colombia-Municipios.com.co [Internet]. Fecha de consulta: 15 de agosto de 2015. Disponible en:http://www.municipios.com.co/

de Vries E, Bray FI, Coebergh JWW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107:119-26.

https://doi.org/10.1002/ijc.11360

Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, et al. Investigation of female survival benefit in metastatic melanoma. Br J Cancer. 1999;80:2025-33.

https://doi.org/10.1038/sj.bjc.6690637

Crombie IK. Racial differences in melanoma incidence. Br J Cancer. 1979;40:185-93.

https://doi.org/10.1038/bjc.1979.165

Departamento Administrativo Nacional de Estadistica (DANE). Colombia una nación multicultural-Su diversidad étnica. Bogotá: DANE; 2007.

How to Cite

1.
García MA. Mortality trends of cutaneous melanoma in Colombia. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 25 [cited 2024 Jul. 3];25(1):8-15. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/317

Downloads

Download data is not yet available.

Published

2019-02-25

How to Cite

1.
García MA. Mortality trends of cutaneous melanoma in Colombia. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2019 Feb. 25 [cited 2024 Jul. 3];25(1):8-15. Available from: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/317

Issue

Section

Research Article
QR Code
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: